Loading…
Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study
Tumor heterogeneity is recognized as a predictor of treatment response and patient outcome. Quantification of tumor heterogeneity across all scales may therefore provide critical insight that ultimately improves cancer management. An image registration-based framework for the study of tumor heteroge...
Saved in:
Published in: | Biomedical engineering online 2023-11, Vol.22 (1), p.1-110, Article 110 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | cdi_FETCH-LOGICAL-c507t-e60e5a1ceb1f08c6b080755e6ed874c144e663dfd2c3f121d0714c20b981da003 |
container_end_page | 110 |
container_issue | 1 |
container_start_page | 1 |
container_title | Biomedical engineering online |
container_volume | 22 |
creator | Jönsson, Hanna Ahlström, Håkan Kullberg, Joel |
description | Tumor heterogeneity is recognized as a predictor of treatment response and patient outcome. Quantification of tumor heterogeneity across all scales may therefore provide critical insight that ultimately improves cancer management. An image registration-based framework for the study of tumor heterogeneity in whole-body images was evaluated on a dataset of 490 FDG-PET-CT images of lung cancer, lymphoma, and melanoma patients. Voxel-, lesion- and subject-level features were extracted from the subjects' segmented lesion masks and mapped to female and male template spaces for voxel-wise analysis. Resulting lesion feature maps of the three subsets of cancer patients were studied visually and quantitatively. Lesion volumes and lesion distances in subject spaces were compared with resulting properties in template space. The strength of the association between subject and template space for these properties was evaluated with Pearson's correlation coefficient. Spatial heterogeneity in terms of lesion frequency distribution in the body, metabolic activity, and lesion volume was seen between the three subsets of cancer patients. Lesion feature maps showed anatomical locations with low versus high mean feature value among lesions sampled in space and also highlighted sites with high variation between lesions in each cancer subset. Spatial properties of the lesion masks in subject space correlated strongly with the same properties measured in template space (lesion volume, R = 0.986, p < 0.001; total metabolic volume, R = 0.988, p < 0.001; maximum within-patient lesion distance, R = 0.997, p < 0.001). Lesion volume and total metabolic volume increased on average from subject to template space (lesion volume, 3.1 [+ or -] 52 ml; total metabolic volume, 53.9 [+ or -] 229 ml). Pair-wise lesion distance decreased on average by 0.1 [+ or -] 1.6 cm and maximum within-patient lesion distance increased on average by 0.5 [+ or -] 2.1 cm from subject to template space. Spatial tumor heterogeneity between subsets of interest in cancer cohorts can successfully be explored in whole-body PET-CT images within the proposed framework. Whole-body studies are, however, especially prone to suffer from regional variation in lesion frequency, and thus statistical power, due to the non-uniform distribution of lesions across a large field of view. |
doi_str_mv | 10.1186/s12938-023-01173-0 |
format | article |
fullrecord | <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d701712cbe284f5b8752f37f5d023126</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A774200807</galeid><doaj_id>oai_doaj_org_article_d701712cbe284f5b8752f37f5d023126</doaj_id><sourcerecordid>A774200807</sourcerecordid><originalsourceid>FETCH-LOGICAL-c507t-e60e5a1ceb1f08c6b080755e6ed874c144e663dfd2c3f121d0714c20b981da003</originalsourceid><addsrcrecordid>eNptkt-K1DAUxosouK6-gFcFbxTsepL-SevdMK46sKDsjuJdSJOTboZO001S1rnbd9g39EnMTEUdkUASDr_zcfjOlyTPCZwRUldvPKFNXmdA8wwIYfF-kJyQgpVZQ8tvD__6P06eeL8BoABVc5JcXo0iGNGnWzGOZuhSq9Mwba1LrzGgsx0OaMIuNUN6e217zFqrdunn8_WPu_vl-m0qUo3Cm9b0e8qHSe2eJo-06D0--_WeJl_en6-XH7OLTx9Wy8VFJktgIcMKsBREYks01LJqoQZWllihqlkhSVFgVeVKKypzTShRwEghKbRNTZQAyE-T1ayrrNjw0ZmtcDtuheGHgnUdFy4Y2SNXDAgjVLZI60KXbc1KqnOmSxUdI7SKWq9nLX-L49Qeqb0zXxcHtWniJWkI7PGXMz46ezOhD3xrvMS-FwPayXNax23kFTugL_5BN3ZyQzSG0wYoodBA84fqRBzXDNoGJ-RelC8YK-KyojmROvsPFY_CrZF2QG1i_ajh1VFDZAJ-D52YvOerq8tjls6sdNZ7h_q3CQT4PmR8DhmPlvFDyDjkPwFmccEE</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2902120909</pqid></control><display><type>article</type><title>Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study</title><source>Publicly Available Content Database</source><source>PubMed Central</source><creator>Jönsson, Hanna ; Ahlström, Håkan ; Kullberg, Joel</creator><creatorcontrib>Jönsson, Hanna ; Ahlström, Håkan ; Kullberg, Joel</creatorcontrib><description>Tumor heterogeneity is recognized as a predictor of treatment response and patient outcome. Quantification of tumor heterogeneity across all scales may therefore provide critical insight that ultimately improves cancer management. An image registration-based framework for the study of tumor heterogeneity in whole-body images was evaluated on a dataset of 490 FDG-PET-CT images of lung cancer, lymphoma, and melanoma patients. Voxel-, lesion- and subject-level features were extracted from the subjects' segmented lesion masks and mapped to female and male template spaces for voxel-wise analysis. Resulting lesion feature maps of the three subsets of cancer patients were studied visually and quantitatively. Lesion volumes and lesion distances in subject spaces were compared with resulting properties in template space. The strength of the association between subject and template space for these properties was evaluated with Pearson's correlation coefficient. Spatial heterogeneity in terms of lesion frequency distribution in the body, metabolic activity, and lesion volume was seen between the three subsets of cancer patients. Lesion feature maps showed anatomical locations with low versus high mean feature value among lesions sampled in space and also highlighted sites with high variation between lesions in each cancer subset. Spatial properties of the lesion masks in subject space correlated strongly with the same properties measured in template space (lesion volume, R = 0.986, p < 0.001; total metabolic volume, R = 0.988, p < 0.001; maximum within-patient lesion distance, R = 0.997, p < 0.001). Lesion volume and total metabolic volume increased on average from subject to template space (lesion volume, 3.1 [+ or -] 52 ml; total metabolic volume, 53.9 [+ or -] 229 ml). Pair-wise lesion distance decreased on average by 0.1 [+ or -] 1.6 cm and maximum within-patient lesion distance increased on average by 0.5 [+ or -] 2.1 cm from subject to template space. Spatial tumor heterogeneity between subsets of interest in cancer cohorts can successfully be explored in whole-body PET-CT images within the proposed framework. Whole-body studies are, however, especially prone to suffer from regional variation in lesion frequency, and thus statistical power, due to the non-uniform distribution of lesions across a large field of view.</description><identifier>ISSN: 1475-925X</identifier><identifier>EISSN: 1475-925X</identifier><identifier>DOI: 10.1186/s12938-023-01173-0</identifier><language>eng</language><publisher>London: BioMed Central Ltd</publisher><subject>Abdomen ; Cancer ; Care and treatment ; Computed tomography ; Correlation coefficient ; Correlation coefficients ; CT imaging ; Diagnosis ; Evaluation ; Feasibility studies ; Feature maps ; Females ; Frequency distribution ; Frequency variation ; Heterogeneity ; Heterogeneous catalysis ; Image registration ; Lesions ; Lung cancer ; Lymphoma ; Males ; Mapping ; Masks ; Medical imaging ; Medical imaging equipment ; Medical research ; Medicine, Experimental ; Melanoma ; Metabolism ; Metastasis ; Non-Hodgkin's lymphomas ; Patients ; PET imaging ; Positron emission ; Radiomics ; Registration ; Spatial heterogeneity ; Standard deviation ; Tomography ; Tumor distribution ; Tumor heterogeneity ; Tumors ; Voxel-wise analysis ; Whole-body PET-CT</subject><ispartof>Biomedical engineering online, 2023-11, Vol.22 (1), p.1-110, Article 110</ispartof><rights>COPYRIGHT 2023 BioMed Central Ltd.</rights><rights>2023. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c507t-e60e5a1ceb1f08c6b080755e6ed874c144e663dfd2c3f121d0714c20b981da003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2902120909?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,25753,27924,27925,37012,37013,44590</link.rule.ids><backlink>$$Uhttps://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-519106$$DView record from Swedish Publication Index$$Hfree_for_read</backlink></links><search><creatorcontrib>Jönsson, Hanna</creatorcontrib><creatorcontrib>Ahlström, Håkan</creatorcontrib><creatorcontrib>Kullberg, Joel</creatorcontrib><title>Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study</title><title>Biomedical engineering online</title><description>Tumor heterogeneity is recognized as a predictor of treatment response and patient outcome. Quantification of tumor heterogeneity across all scales may therefore provide critical insight that ultimately improves cancer management. An image registration-based framework for the study of tumor heterogeneity in whole-body images was evaluated on a dataset of 490 FDG-PET-CT images of lung cancer, lymphoma, and melanoma patients. Voxel-, lesion- and subject-level features were extracted from the subjects' segmented lesion masks and mapped to female and male template spaces for voxel-wise analysis. Resulting lesion feature maps of the three subsets of cancer patients were studied visually and quantitatively. Lesion volumes and lesion distances in subject spaces were compared with resulting properties in template space. The strength of the association between subject and template space for these properties was evaluated with Pearson's correlation coefficient. Spatial heterogeneity in terms of lesion frequency distribution in the body, metabolic activity, and lesion volume was seen between the three subsets of cancer patients. Lesion feature maps showed anatomical locations with low versus high mean feature value among lesions sampled in space and also highlighted sites with high variation between lesions in each cancer subset. Spatial properties of the lesion masks in subject space correlated strongly with the same properties measured in template space (lesion volume, R = 0.986, p < 0.001; total metabolic volume, R = 0.988, p < 0.001; maximum within-patient lesion distance, R = 0.997, p < 0.001). Lesion volume and total metabolic volume increased on average from subject to template space (lesion volume, 3.1 [+ or -] 52 ml; total metabolic volume, 53.9 [+ or -] 229 ml). Pair-wise lesion distance decreased on average by 0.1 [+ or -] 1.6 cm and maximum within-patient lesion distance increased on average by 0.5 [+ or -] 2.1 cm from subject to template space. Spatial tumor heterogeneity between subsets of interest in cancer cohorts can successfully be explored in whole-body PET-CT images within the proposed framework. Whole-body studies are, however, especially prone to suffer from regional variation in lesion frequency, and thus statistical power, due to the non-uniform distribution of lesions across a large field of view.</description><subject>Abdomen</subject><subject>Cancer</subject><subject>Care and treatment</subject><subject>Computed tomography</subject><subject>Correlation coefficient</subject><subject>Correlation coefficients</subject><subject>CT imaging</subject><subject>Diagnosis</subject><subject>Evaluation</subject><subject>Feasibility studies</subject><subject>Feature maps</subject><subject>Females</subject><subject>Frequency distribution</subject><subject>Frequency variation</subject><subject>Heterogeneity</subject><subject>Heterogeneous catalysis</subject><subject>Image registration</subject><subject>Lesions</subject><subject>Lung cancer</subject><subject>Lymphoma</subject><subject>Males</subject><subject>Mapping</subject><subject>Masks</subject><subject>Medical imaging</subject><subject>Medical imaging equipment</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Melanoma</subject><subject>Metabolism</subject><subject>Metastasis</subject><subject>Non-Hodgkin's lymphomas</subject><subject>Patients</subject><subject>PET imaging</subject><subject>Positron emission</subject><subject>Radiomics</subject><subject>Registration</subject><subject>Spatial heterogeneity</subject><subject>Standard deviation</subject><subject>Tomography</subject><subject>Tumor distribution</subject><subject>Tumor heterogeneity</subject><subject>Tumors</subject><subject>Voxel-wise analysis</subject><subject>Whole-body PET-CT</subject><issn>1475-925X</issn><issn>1475-925X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkt-K1DAUxosouK6-gFcFbxTsepL-SevdMK46sKDsjuJdSJOTboZO001S1rnbd9g39EnMTEUdkUASDr_zcfjOlyTPCZwRUldvPKFNXmdA8wwIYfF-kJyQgpVZQ8tvD__6P06eeL8BoABVc5JcXo0iGNGnWzGOZuhSq9Mwba1LrzGgsx0OaMIuNUN6e217zFqrdunn8_WPu_vl-m0qUo3Cm9b0e8qHSe2eJo-06D0--_WeJl_en6-XH7OLTx9Wy8VFJktgIcMKsBREYks01LJqoQZWllihqlkhSVFgVeVKKypzTShRwEghKbRNTZQAyE-T1ayrrNjw0ZmtcDtuheGHgnUdFy4Y2SNXDAgjVLZI60KXbc1KqnOmSxUdI7SKWq9nLX-L49Qeqb0zXxcHtWniJWkI7PGXMz46ezOhD3xrvMS-FwPayXNax23kFTugL_5BN3ZyQzSG0wYoodBA84fqRBzXDNoGJ-RelC8YK-KyojmROvsPFY_CrZF2QG1i_ajh1VFDZAJ-D52YvOerq8tjls6sdNZ7h_q3CQT4PmR8DhmPlvFDyDjkPwFmccEE</recordid><startdate>20231125</startdate><enddate>20231125</enddate><creator>Jönsson, Hanna</creator><creator>Ahlström, Håkan</creator><creator>Kullberg, Joel</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7QO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>M7S</scope><scope>P64</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>7X8</scope><scope>ACNBI</scope><scope>ADTPV</scope><scope>AOWAS</scope><scope>D8T</scope><scope>DF2</scope><scope>ZZAVC</scope><scope>DOA</scope></search><sort><creationdate>20231125</creationdate><title>Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study</title><author>Jönsson, Hanna ; Ahlström, Håkan ; Kullberg, Joel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c507t-e60e5a1ceb1f08c6b080755e6ed874c144e663dfd2c3f121d0714c20b981da003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Abdomen</topic><topic>Cancer</topic><topic>Care and treatment</topic><topic>Computed tomography</topic><topic>Correlation coefficient</topic><topic>Correlation coefficients</topic><topic>CT imaging</topic><topic>Diagnosis</topic><topic>Evaluation</topic><topic>Feasibility studies</topic><topic>Feature maps</topic><topic>Females</topic><topic>Frequency distribution</topic><topic>Frequency variation</topic><topic>Heterogeneity</topic><topic>Heterogeneous catalysis</topic><topic>Image registration</topic><topic>Lesions</topic><topic>Lung cancer</topic><topic>Lymphoma</topic><topic>Males</topic><topic>Mapping</topic><topic>Masks</topic><topic>Medical imaging</topic><topic>Medical imaging equipment</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Melanoma</topic><topic>Metabolism</topic><topic>Metastasis</topic><topic>Non-Hodgkin's lymphomas</topic><topic>Patients</topic><topic>PET imaging</topic><topic>Positron emission</topic><topic>Radiomics</topic><topic>Registration</topic><topic>Spatial heterogeneity</topic><topic>Standard deviation</topic><topic>Tomography</topic><topic>Tumor distribution</topic><topic>Tumor heterogeneity</topic><topic>Tumors</topic><topic>Voxel-wise analysis</topic><topic>Whole-body PET-CT</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jönsson, Hanna</creatorcontrib><creatorcontrib>Ahlström, Håkan</creatorcontrib><creatorcontrib>Kullberg, Joel</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest Engineering Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering collection</collection><collection>MEDLINE - Academic</collection><collection>SWEPUB Uppsala universitet full text</collection><collection>SwePub</collection><collection>SwePub Articles</collection><collection>SWEPUB Freely available online</collection><collection>SWEPUB Uppsala universitet</collection><collection>SwePub Articles full text</collection><collection>Directory of Open Access Journals</collection><jtitle>Biomedical engineering online</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jönsson, Hanna</au><au>Ahlström, Håkan</au><au>Kullberg, Joel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study</atitle><jtitle>Biomedical engineering online</jtitle><date>2023-11-25</date><risdate>2023</risdate><volume>22</volume><issue>1</issue><spage>1</spage><epage>110</epage><pages>1-110</pages><artnum>110</artnum><issn>1475-925X</issn><eissn>1475-925X</eissn><abstract>Tumor heterogeneity is recognized as a predictor of treatment response and patient outcome. Quantification of tumor heterogeneity across all scales may therefore provide critical insight that ultimately improves cancer management. An image registration-based framework for the study of tumor heterogeneity in whole-body images was evaluated on a dataset of 490 FDG-PET-CT images of lung cancer, lymphoma, and melanoma patients. Voxel-, lesion- and subject-level features were extracted from the subjects' segmented lesion masks and mapped to female and male template spaces for voxel-wise analysis. Resulting lesion feature maps of the three subsets of cancer patients were studied visually and quantitatively. Lesion volumes and lesion distances in subject spaces were compared with resulting properties in template space. The strength of the association between subject and template space for these properties was evaluated with Pearson's correlation coefficient. Spatial heterogeneity in terms of lesion frequency distribution in the body, metabolic activity, and lesion volume was seen between the three subsets of cancer patients. Lesion feature maps showed anatomical locations with low versus high mean feature value among lesions sampled in space and also highlighted sites with high variation between lesions in each cancer subset. Spatial properties of the lesion masks in subject space correlated strongly with the same properties measured in template space (lesion volume, R = 0.986, p < 0.001; total metabolic volume, R = 0.988, p < 0.001; maximum within-patient lesion distance, R = 0.997, p < 0.001). Lesion volume and total metabolic volume increased on average from subject to template space (lesion volume, 3.1 [+ or -] 52 ml; total metabolic volume, 53.9 [+ or -] 229 ml). Pair-wise lesion distance decreased on average by 0.1 [+ or -] 1.6 cm and maximum within-patient lesion distance increased on average by 0.5 [+ or -] 2.1 cm from subject to template space. Spatial tumor heterogeneity between subsets of interest in cancer cohorts can successfully be explored in whole-body PET-CT images within the proposed framework. Whole-body studies are, however, especially prone to suffer from regional variation in lesion frequency, and thus statistical power, due to the non-uniform distribution of lesions across a large field of view.</abstract><cop>London</cop><pub>BioMed Central Ltd</pub><doi>10.1186/s12938-023-01173-0</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1475-925X |
ispartof | Biomedical engineering online, 2023-11, Vol.22 (1), p.1-110, Article 110 |
issn | 1475-925X 1475-925X |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_d701712cbe284f5b8752f37f5d023126 |
source | Publicly Available Content Database; PubMed Central |
subjects | Abdomen Cancer Care and treatment Computed tomography Correlation coefficient Correlation coefficients CT imaging Diagnosis Evaluation Feasibility studies Feature maps Females Frequency distribution Frequency variation Heterogeneity Heterogeneous catalysis Image registration Lesions Lung cancer Lymphoma Males Mapping Masks Medical imaging Medical imaging equipment Medical research Medicine, Experimental Melanoma Metabolism Metastasis Non-Hodgkin's lymphomas Patients PET imaging Positron emission Radiomics Registration Spatial heterogeneity Standard deviation Tomography Tumor distribution Tumor heterogeneity Tumors Voxel-wise analysis Whole-body PET-CT |
title | Spatial mapping of tumor heterogeneity in whole-body PET–CT: a feasibility study |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T03%3A24%3A35IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Spatial%20mapping%20of%20tumor%20heterogeneity%20in%20whole-body%20PET%E2%80%93CT:%20a%20feasibility%20study&rft.jtitle=Biomedical%20engineering%20online&rft.au=J%C3%B6nsson,%20Hanna&rft.date=2023-11-25&rft.volume=22&rft.issue=1&rft.spage=1&rft.epage=110&rft.pages=1-110&rft.artnum=110&rft.issn=1475-925X&rft.eissn=1475-925X&rft_id=info:doi/10.1186/s12938-023-01173-0&rft_dat=%3Cgale_doaj_%3EA774200807%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c507t-e60e5a1ceb1f08c6b080755e6ed874c144e663dfd2c3f121d0714c20b981da003%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2902120909&rft_id=info:pmid/&rft_galeid=A774200807&rfr_iscdi=true |